Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 40, 2010 - Issue 6
147
Views
8
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Metabolism, pharmacokinetics and excretion of the GABAA receptor partial agonist [14C]CP-409,092 in rats

, , &
Pages 400-414 | Received 19 Dec 2009, Accepted 17 Feb 2010, Published online: 24 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Roberto Mandrioli & Laura Mercolini. (2015) Discontinued anxiolytic drugs (2009 – 2014). Expert Opinion on Investigational Drugs 24:4, pages 557-573.
Read now
Aarti Sawant Basak, Wonkyung Byon, Elaine Tseng-Lovering, Carrie Funk, Linda Wood, Chang Lin, Marielle Delnomdedieu, Patrick Verhoest, Vinod Parikh, Loretta M. Cox, Emily Miller, Hongying Gao & Ronald S. Obach. (2014) Metabolism and clinical pharmacokinetics of 2-methyl-n-(2′-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1′-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration of in vitro ADME tools. Xenobiotica 44:5, pages 438-454.
Read now
A.D. Sawant, E.L. Miller, D.B. Duignan, J. Brodfuehrer, S.M. Winter, F.R. Nelson, A. Kamel, R.S. Obach & A.D.N. Vaz. (2010) Understanding the clinical pharmacokinetics of a GABAA partial agonist by application of in vitro tools. Xenobiotica 40:7, pages 476-484.
Read now

Articles from other publishers (4)

Deepak Dalvie & Sekhar Surapaneni. 2023. Overcoming Obstacles in Drug Discovery and Development. Overcoming Obstacles in Drug Discovery and Development 239 247 .
April Bai, Veerabahu Shanmugasundaram, Julie V. Selkirk, Sekhar Surapaneni & Deepak Dalvie. (2021) Investigation into MAO B–Mediated Formation of CC112273, a Major Circulating Metabolite of Ozanimod, in Humans and Preclinical Species: Stereospecific Oxidative Deamination of ( S )-Enantiomer of Indaneamine (RP101075) by MAO B . Drug Metabolism and Disposition 49:8, pages 601-609.
Crossref
Tomas Horsten & Wim Dehaen. (2021) 4,5,6,7-Tetrahydroindol-4-Ones as a Valuable Starting Point for the Synthesis of Polyheterocyclic Structures. Molecules 26:15, pages 4596.
Crossref
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design 111 158 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.